Anthropic is running its own drug programs after acquiring a one-person biotech

First reported by Quartz at · Updated · 1 source

Anthropic released early results from drug development work with six partners, including Bristol Myers Squibb

Reported so far by one publisher.

Summary from Quartz.

Reporting1

Quartz Anthropic is running its own drug programs after acquiring a one-person biotech · Cris Tolomia

Related

Anthropic’s IPO Could Be Historic But What Will Investors Own?
Anthropic’s Latest Claude Security Disclosure Will Make You Sympathize With Claude
Goldman Sachs to Lead Anthropic IPO
Replit makes OpenAI its default over Anthropic, CEO says

Topics Anthropic